These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 520769)

  • 1. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure.
    Okita K; Matsuda S; Hata K; Morimoto T; Sasaki M; Fukumoto Y; Kodama T; Takemoto T
    Gastroenterol Jpn; 1979 Oct; 14(5):453-7. PubMed ID: 520769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.
    Woolf GM; Redeker AG
    Dig Dis Sci; 1991 Jan; 36(1):92-6. PubMed ID: 1702048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hepatic encephalopathy with glucagon-insulin (author's transl)].
    Fujishima A; Fujita H; Saito M; Shirai Y; Suga M; Hosokawa Y; Yokoyama Y; Kinoshita H; Anzai T
    Nihon Shokakibyo Gakkai Zasshi; 1980 Dec; 77(12):1948-54. PubMed ID: 7009930
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and glucagon infusion in the treatment of liver failure.
    Jaspan JB; Landau RL; Schneider J
    Arch Intern Med; 1984 Oct; 144(10):2075-8. PubMed ID: 6385900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of insulin and glucagon in fulminant murine viral hepatitis.
    Farivar M; Wands JR; Isselbacher KJ; Bucher NL
    Lancet; 1976 Mar; 1(7961):696-7. PubMed ID: 73670
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of insulin glucose administration in fulminant hepatic failure.
    Burn J; Williams WD
    Intensive Care Med; 1978 Jul; 4(3):133-6. PubMed ID: 690322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction, diagnosis and therapy of fulminant hepatitis].
    Muto Y; Murakami N; Sugihara J
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1012-7. PubMed ID: 2230480
    [No Abstract]   [Full Text] [Related]  

  • 9. A trial of glucagon in fulminant hepatitis.
    Narendranathan M; Nandini KK; Balakrishnan V
    J Assoc Physicians India; 1985 Mar; 33(3):219-20. PubMed ID: 4044480
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.
    Okita K; Matsuda S; Hanta T; Yasunaga M; Sanuki K; Takemoto T
    Gastroenterol Jpn; 1987 Oct; 22(5):607-13. PubMed ID: 3315819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative glucagon-insulin therapy on the patient with hepatic failure secondary to combined valvular disease].
    Kumagae T; Morishita Y; Yuda T; Shimokawa S; Umebayashi Y; Higashi T; Taira A
    Kyobu Geka; 1984 Aug; 37(9 Suppl):732-5. PubMed ID: 6389951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Imbalance of amino acid metabolism in fulminant hepatitis and its management].
    Kato A; Suzuki K; Sato S
    Nihon Rinsho; 1992 Jul; 50(7):1599-603. PubMed ID: 1404890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin and glucagon on serum amino acid concentrations in liver disease.
    Watanabe A; Higashi T; Hayashi S; Obata T; Sakata T; Takei N; Shiota T; Nagashima H
    Acta Med Okayama; 1982 Dec; 36(6):441-6. PubMed ID: 6760674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of autoimmune hepatitis recovered from a fulminant like severe hepatic failure].
    Ohnishi K; Torimoto Y; Ohhira M; Yasuda A; Matsumoto A; Murazumi Y; Mizuno M; Murazumi K; Ohta H; Kohda H
    Nihon Shokakibyo Gakkai Zasshi; 1994 Sep; 91(9):1457-63. PubMed ID: 7933646
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of insulin and glucagon on fulminant murine hepatitis.
    Farivar M; Wands JR; Isselbacher KJ; Bucher NL
    N Engl J Med; 1976 Dec; 295(27):1517-9. PubMed ID: 995158
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic encephalopathy in the aged].
    Muto Y; Murase M
    Nihon Naika Gakkai Zasshi; 1990 Apr; 79(4):468-74. PubMed ID: 2115560
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis.
    Fehér J; Cornides A; Romány A; Kárteszi M; Szalay L; Gógl A; Picazo J
    J Hepatol; 1987 Oct; 5(2):224-31. PubMed ID: 3320181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
    Castaldi C; D'Amore F; Materia E; Mauceri M; Rivosecchi L
    Minerva Cardioangiol; 1978 Nov; 26(11):751-6. PubMed ID: 724124
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nursing care of the patient with fulminant hepatitis undergoing glucagon-insulin therapy].
    Nakano M; Ota M; Tominaga C; Ono J; Matsuda N
    Kango Gijutsu; 1984 Sep; 30(12):1605-12. PubMed ID: 6384594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.